• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Perceptions about traditional Chinese medicine use among Chinese breast cancer survivors: A qualitative study.中国乳腺癌幸存者对中医药使用的认知:一项定性研究。
Cancer Med. 2023 Jan;12(2):1997-2007. doi: 10.1002/cam4.5046. Epub 2022 Sep 8.
2
Delivery of patient-centered care in complementary medicine: Insights and evidence from the Chinese medical practitioners and patients in primary care consultations in Hong Kong.在补充医学中提供以患者为中心的护理:来自香港基层医疗中医从业者和患者的见解和证据。
Complement Ther Med. 2019 Aug;45:198-204. doi: 10.1016/j.ctim.2019.06.013. Epub 2019 Jun 20.
3
Navigating communication between conventional medicine and traditional Chinese medicine: a case study of cancer patients in Hong Kong.协调传统医学与中医药之间的沟通:以香港癌症患者为例的研究。
Support Care Cancer. 2022 Jul;30(7):5729-5735. doi: 10.1007/s00520-022-06986-8. Epub 2022 Mar 24.
4
An exploratory study of communication training for Chinese medicine practitioners in Hong Kong to integrate patients' conventional medical history.一项关于为香港中医师提供沟通培训以整合患者常规病史的探索性研究。
BMC Complement Med Ther. 2023 Jan 12;23(1):10. doi: 10.1186/s12906-022-03811-x.
5
Revisiting Traditional Chinese Medicine in Hong Kong during the Influenza Epidemics in the 1950s and 1960s.重温 20 世纪 50 年代和 60 年代香港流感大流行期间的中医药
Uisahak. 2024 Apr;33(1):191-229. doi: 10.13081/kjmh.2024.33.191.
6
Physical distress and cancer care experiences among Chinese-American and non-Hispanic White breast cancer survivors.美籍华裔和非西班牙裔白种乳腺癌幸存者的身体不适和癌症护理体验。
Gynecol Oncol. 2012 Mar;124(3):383-8. doi: 10.1016/j.ygyno.2011.11.029. Epub 2011 Nov 22.
7
Current Usage of Traditional Chinese Medicine for Breast Cancer-A Narrative Approach to the Experiences of Women with Breast Cancer in Australia-A Pilot Study.澳大利亚乳腺癌患者使用中药的现状——对澳大利亚乳腺癌女性经历的叙述性研究——一项试点研究
Medicines (Basel). 2017 Apr 21;4(2):20. doi: 10.3390/medicines4020020.
8
Age, chronic non-communicable disease and choice of traditional Chinese and western medicine outpatient services in a Chinese population.年龄、慢性非传染性疾病与中国人群选择中、西医门诊服务。
BMC Health Serv Res. 2009 Nov 17;9:207. doi: 10.1186/1472-6963-9-207.
9
Dilemma of integration with Western medicine - views of Traditional Chinese Medicine practitioners in a predominant Western medical setting.中西医结合的困境——以西医为主的环境中中医从业者的观点。
Complement Ther Med. 2013 Aug;21(4):300-5. doi: 10.1016/j.ctim.2013.04.003. Epub 2013 May 31.
10
Adoption of healthy lifestyles among Chinese cancer survivors during the first five years after completion of treatment.中国癌症患者治疗完成后五年内健康生活方式的采用情况。
Ethn Health. 2022 Jan;27(1):137-156. doi: 10.1080/13557858.2019.1634182. Epub 2019 Jun 25.

引用本文的文献

1
Home-based self-management using Traditional Chinese Medicine techniques: empowerment and risks in breast cancer survivors' fulfillment of health-deviation self-care requisites.使用中医技术的居家自我管理:乳腺癌幸存者满足健康偏差自我护理要求中的赋权与风险
J Cancer Surviv. 2025 May 9. doi: 10.1007/s11764-025-01808-2.
2
Factors influencing the utilization of Traditional Chinese Medicine in cancer treatment: a qualitative meta-synthesis of patient and healthcare professional perspectives.影响中医在癌症治疗中应用的因素:基于患者和医护人员观点的定性元分析
Front Med (Lausanne). 2025 Mar 5;12:1501918. doi: 10.3389/fmed.2025.1501918. eCollection 2025.
3
Cutting-edge and topical issues in the treatment of breast cancer with traditional Chinese medicine based on CiteSpace bibliometric analysis.基于CiteSpace文献计量分析的中医治疗乳腺癌前沿与热点问题
Medicine (Baltimore). 2024 Dec 6;103(49):e40784. doi: 10.1097/MD.0000000000040784.
4
Targeting signaling pathways with andrographolide in cancer therapy (Review).穿心莲内酯在癌症治疗中靶向信号通路(综述)。
Mol Clin Oncol. 2024 Sep 5;21(5):81. doi: 10.3892/mco.2024.2779. eCollection 2024 Nov.
5
n-hexane extract suppressed breast cancer progression through induction of G0/G1 phase arrest and apoptotic cell death by inhibiting the Cyclin D1/CDK4-Rb signaling pathway.正己烷提取物通过抑制细胞周期蛋白D1/细胞周期蛋白依赖性激酶4-视网膜母细胞瘤蛋白(Cyclin D1/CDK4-Rb)信号通路,诱导G0/G1期阻滞和凋亡性细胞死亡,从而抑制乳腺癌进展。
Front Pharmacol. 2024 Aug 5;15:1425157. doi: 10.3389/fphar.2024.1425157. eCollection 2024.
6
Perceptions, Attitudes, Beliefs, and Practices Toward Traditional Chinese Medicine Therapies for Herpes Zoster: A Cross-Sectional Study of Healthcare Professionals.医疗保健专业人员对带状疱疹中医治疗的认知、态度、信念及实践:一项横断面研究
Risk Manag Healthc Policy. 2024 May 14;17:1239-1251. doi: 10.2147/RMHP.S461149. eCollection 2024.

本文引用的文献

1
Estimated Projection of US Cancer Incidence and Death to 2040.预估 2040 年美国癌症发病与死亡人数。
JAMA Netw Open. 2021 Apr 1;4(4):e214708. doi: 10.1001/jamanetworkopen.2021.4708.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
Association between cancer-related fatigue and traditional Chinese medicine body constitution in female patients with breast cancer.乳腺癌女性患者癌因性疲乏与中医体质的相关性
J Tradit Complement Med. 2020 Aug 31;11(1):62-67. doi: 10.1016/j.jtcme.2020.08.005. eCollection 2021 Jan.
4
Breast Cancer Survivorship, Quality of Life, and Late Toxicities.乳腺癌幸存者、生活质量及晚期毒性反应
Front Oncol. 2020 Jun 16;10:864. doi: 10.3389/fonc.2020.00864. eCollection 2020.
5
Cancer treatment and survivorship statistics, 2019.2019 年癌症治疗与生存统计
CA Cancer J Clin. 2019 Sep;69(5):363-385. doi: 10.3322/caac.21565. Epub 2019 Jun 11.
6
Grounded theory research: A design framework for novice researchers.扎根理论研究:新手研究者的设计框架。
SAGE Open Med. 2019 Jan 2;7:2050312118822927. doi: 10.1177/2050312118822927. eCollection 2019.
7
Fatigue after breast cancer treatment: Biobehavioral predictors of fatigue trajectories.乳腺癌治疗后的疲劳:疲劳轨迹的生物行为预测因素。
Health Psychol. 2018 Nov;37(11):1025-1034. doi: 10.1037/hea0000652.
8
Nephrotoxicity and Chinese Herbal Medicine.肾毒性与中草药。
Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1605-1611. doi: 10.2215/CJN.11571017. Epub 2018 Apr 3.
9
Current Usage of Traditional Chinese Medicine for Breast Cancer-A Narrative Approach to the Experiences of Women with Breast Cancer in Australia-A Pilot Study.澳大利亚乳腺癌患者使用中药的现状——对澳大利亚乳腺癌女性经历的叙述性研究——一项试点研究
Medicines (Basel). 2017 Apr 21;4(2):20. doi: 10.3390/medicines4020020.
10
Use of Complementary Traditional Chinese Medicines by Adult Cancer Patients in Taiwan: A Nationwide Population-Based Study.台湾成年癌症患者使用补充性中药的情况:一项基于全国人口的研究。
Integr Cancer Ther. 2018 Jun;17(2):531-541. doi: 10.1177/1534735417716302. Epub 2017 Jun 30.

中国乳腺癌幸存者对中医药使用的认知:一项定性研究。

Perceptions about traditional Chinese medicine use among Chinese breast cancer survivors: A qualitative study.

机构信息

Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong.

Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong.

出版信息

Cancer Med. 2023 Jan;12(2):1997-2007. doi: 10.1002/cam4.5046. Epub 2022 Sep 8.

DOI:10.1002/cam4.5046
PMID:36073533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9883569/
Abstract

INTRODUCTION

An increasing number of breast cancer survivors (BCS) use traditional Chinese medicine (TCM) throughout their cancer journey. There is emerging evidence that TCM is effective in the reducing side effects of chemotherapy. However, qualitative patient-centric and culturally relevant research into TCM use is scant. This qualitative study aimed to explore the use and perceptions of Chinese Hong Kong BCS using TCM.

METHODS

Participants were recruited from a university hospital and three breast cancer patient groups in Hong Kong. Questionnaires regarding the use of TCM were given to all participants, followed by individual semi-structured interviews on selected BCS to comprehensively understand TCM's use and perceptions. A greater emphasis was placed on the qualitative data.

RESULTS

About half of the participants (n = 67, 48.9%) used TCM during their cancer treatment journey, among which almost all (n = 64, 95.5%) had improved symptoms. Sleeping disturbances (n = 58, 86.6%) and fatigue (n = 53, 79.1%) were the two most common symptoms that improved after TCM. Interview data revealed that participants used TCM to satisfy unmet needs that mainstream conventional Western medicine could not fulfil. They wished for a sense of control and better well-being. They expressed improvements in physical and psychological well-being after the use of TCM. Despite existing barriers, including high cost, long duration of treatment, and disapproval from oncologists, most would still recommend TCM to fellow survivors.

CONCLUSIONS

Chinese Hong Kong BCS who used TCM reported positive experiences. Understanding how BCS perceive and use TCM is important to integrating TCM into survivorship care in this population.

摘要

简介

越来越多的乳腺癌幸存者(BCS)在癌症治疗过程中使用传统中医(TCM)。有新证据表明 TCM 可有效减轻化疗副作用。然而,关于 TCM 使用的以患者为中心且具有文化相关性的定性研究却很少。本定性研究旨在探索香港乳腺癌幸存者使用 TCM 的情况和认知。

方法

参与者均来自香港一所大学医院和三个乳腺癌患者团体。所有参与者都被发放了关于 TCM 使用的问卷,然后对选定的 BCS 进行单独的半结构式访谈,以全面了解 TCM 的使用情况和认知。更注重定性数据。

结果

约一半的参与者(n=67,48.9%)在癌症治疗过程中使用了 TCM,其中几乎所有人(n=64,95.5%)的症状都有所改善。TCM 改善的最常见症状是睡眠障碍(n=58,86.6%)和疲劳(n=53,79.1%)。访谈数据显示,参与者使用 TCM 是为了满足主流常规西医无法满足的未满足需求。他们希望获得掌控感和更好的幸福感。他们表示在使用 TCM 后,身体和心理健康都有所改善。尽管存在成本高、治疗时间长以及肿瘤医生反对等障碍,但大多数人仍会向其他幸存者推荐 TCM。

结论

使用 TCM 的中国香港 BCS 报告了积极的体验。了解 BCS 如何看待和使用 TCM 对于将 TCM 融入该人群的生存护理至关重要。